Pharmacogenomics: the Future of Drug Development of Patient care

Sandhya S.Ahire; Sujeetkumar I.Ahire; Miss. Prachi Chaudhari; Chetan Chaudhari

Pharmacogenomics: the Future of Drug Development of Patient care

Authors: Sandhya S.Ahire, Sujeetkumar I.Ahire, Miss. Prachi Chaudhari, Chetan Chaudhari

Unique Paper ID: 174318
Volume: 11
Issue: 10
PageNo: 4577-4585

Keywords: clinical practice pharmacogenetics pharmacogenes clinical practice.

Abstract:
This study investigates the possible effects of pharmacogenomics, a quickly emerging field that examines the use of genomic markers to forecast how a medicine will be treated. Research on the genetic components that influence individual variations in drug response is part of the rapidly evolving field of pharmacogenomics. A substantial pharmacogenomics knowledge gap in the healthcare workforce and the shift in current therapeutic pathways are two major implementation issues that still arise at the point of delivery into health-care systems. Pharmacogenomics may find wider application in drug research and development as evidence mounts that targets with a genetic definition have a higher success rate throughout clinical development. Pharmaceutical prescribing and dosage can now be done in a particular way thanks to Research on the genetic basis of diversity in medication response has enabled a particular approach to pharmaceutical prescribing and dosing. Here, we address the current status of the field, strategies for addressing some unresolved problems, and the application of pharmacogenomics to guide medication therapy through genetic testing. Future pharmaceutical development may be significantly impacted by pharmacogenomics. This tactic can lessen side effects, halt ineffective treatments, and enhance patients' overall health. As pharmacogenomics data becomes more accessible and incorporated into clinical practice, it has the potential to change the way healthcare is delivered, improving patient satisfaction and results.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 10
PageNo: 4577-4585

Pharmacogenomics: the Future of Drug Development of Patient care

Available:https://ijirt.org/Article?manuscript=174318

11 Mar, 2025

ETHOSOMES A REVIEW

06 Mar, 2025

A Research on the Role of Nutrition in Substance Abuse Recovery

06 Dec, 2024

Self-Emulsifying Drug Delivery Systems; An Overview

16 Nov, 2024

OVERVIEW OF PHARMACOVIGILANCE AND THEIR ICH GUIDELINES

26 Oct, 2024

Vitamin B12 Deficiency In Older People A Practical Approach To Recognition And Management.

16 Oct, 2024

Analytical Method Developement and Validation of Beclomethasone, Clotrimazole by RP-HPLC in Combination Dosage Form.

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry